[
  {
    "ts": null,
    "headline": "Novo Nordisk Shares Plunge After New Obesity Shot Disappoints",
    "summary": "Shares in the company dived after a new anti-obesity treatment missed expectations in a study, denting its chances of becoming the company’s next blockbuster weight loss drug.",
    "url": "https://finnhub.io/api/news?id=9ee3a9cdcf66fd04e663d7ee60b6f67cbc9e6ae9267b93420a2dc44abe95cd38",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734724080,
      "headline": "Novo Nordisk Shares Plunge After New Obesity Shot Disappoints",
      "id": 132080045,
      "image": "",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Shares in the company dived after a new anti-obesity treatment missed expectations in a study, denting its chances of becoming the company’s next blockbuster weight loss drug.",
      "url": "https://finnhub.io/api/news?id=9ee3a9cdcf66fd04e663d7ee60b6f67cbc9e6ae9267b93420a2dc44abe95cd38"
    }
  },
  {
    "ts": null,
    "headline": "Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.",
    "summary": "Novo Nordisk stock crashed Friday after the firm's next-generation weight-loss drug missed expectations in a highly anticipated study.",
    "url": "https://finnhub.io/api/news?id=dc041da50e6e44284cc65bce2bc914dfd8fabf08d2b05a05c3ef84355fb1c036",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734719769,
      "headline": "Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.",
      "id": 132079421,
      "image": "https://media.zenfs.com/en/ibd.com/46c18cf5ac864a5f2306cbef485a793d",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Novo Nordisk stock crashed Friday after the firm's next-generation weight-loss drug missed expectations in a highly anticipated study.",
      "url": "https://finnhub.io/api/news?id=dc041da50e6e44284cc65bce2bc914dfd8fabf08d2b05a05c3ef84355fb1c036"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. stock rises Friday, still underperforms market",
    "summary": "Amgen Inc. stock rises Friday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=420c82d7542ec1f63ee6374cf60d0aab28aa84fb27372d85b0e93eeb895e6341",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734712740,
      "headline": "Amgen Inc. stock rises Friday, still underperforms market",
      "id": 132147764,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock rises Friday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=420c82d7542ec1f63ee6374cf60d0aab28aa84fb27372d85b0e93eeb895e6341"
    }
  },
  {
    "ts": null,
    "headline": "Dow up 650 points on gains for shares of Goldman Sachs, NVIDIA Corp.",
    "summary": "Dow up 650 points on gains for shares of Goldman Sachs, NVIDIA Corp.",
    "url": "https://finnhub.io/api/news?id=2106487ed0c0f7df464e8d4885aead3b2bd2cec5740072cb5d1e9e7b9b9f0a7d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734701580,
      "headline": "Dow up 650 points on gains for shares of Goldman Sachs, NVIDIA Corp.",
      "id": 132145689,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Dow up 650 points on gains for shares of Goldman Sachs, NVIDIA Corp.",
      "url": "https://finnhub.io/api/news?id=2106487ed0c0f7df464e8d4885aead3b2bd2cec5740072cb5d1e9e7b9b9f0a7d"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.",
    "summary": "Novo Nordisk stock crashed Friday after the Danish giant reported its experimental obesity drug CagriSegma missed goals. Eli Lilly and Viking Therapeutics jumped",
    "url": "https://finnhub.io/api/news?id=936f47d99c8a4549bb27b69c5bd0f2d3c76323b59add70e122ba8e9ecbe1c59f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734696189,
      "headline": "Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.",
      "id": 132071759,
      "image": "https://media.zenfs.com/en/ibd.com/46c18cf5ac864a5f2306cbef485a793d",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Novo Nordisk stock crashed Friday after the Danish giant reported its experimental obesity drug CagriSegma missed goals. Eli Lilly and Viking Therapeutics jumped",
      "url": "https://finnhub.io/api/news?id=936f47d99c8a4549bb27b69c5bd0f2d3c76323b59add70e122ba8e9ecbe1c59f"
    }
  },
  {
    "ts": null,
    "headline": "Goldman Sachs, Salesforce share gains lead Dow's 300-point jump",
    "summary": "Goldman Sachs, Salesforce share gains lead Dow's 300-point jump",
    "url": "https://finnhub.io/api/news?id=c9118a2b8f5b5b78370644b27242912d2fd3c472f3ea265438a46d661d11fb1f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734690600,
      "headline": "Goldman Sachs, Salesforce share gains lead Dow's 300-point jump",
      "id": 132145532,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Goldman Sachs, Salesforce share gains lead Dow's 300-point jump",
      "url": "https://finnhub.io/api/news?id=c9118a2b8f5b5b78370644b27242912d2fd3c472f3ea265438a46d661d11fb1f"
    }
  }
]